Korean J Intern Med.
2024 Sep;39(5):717-790. 10.3904/kjim.2024.156.
2024 KSoLA consensus on secondary dyslipidemia
- Won H1
- Bae JH2
- Lim H3,4
- Kang M3,4
- Kim M5
- Lee SH
6 - on behalf of the Clinical Practice Guidelines Committee, Korean Society of Lipid and Atherosclerosis (KSoLA)1
- Affiliations
-
- 1Cardiovascular-Arrhythmia Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea
- 2Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
- 3Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Korea
- 4Research Institute of Medical Nutrition, Kyung Hee University, Seoul, Korea
- 5Department of Food and Nutrition, College of Life Science and Nano Technology, Hannam University, Daejeon, Korea
- 6Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2558764
- DOI: http://doi.org/10.3904/kjim.2024.156
Abstract
- Elevated blood cholesterol and triglyceride levels induced by secondary causes are frequently observed. The identification and appropriate handling of these causes are essential for secondary dyslipidemia treatment. Major secondary causes of hypercholesterolemia and hypertriglyceridemia include an unhealthy diet, diseases and metabolic conditions affecting lipid levels, and therapeutic side effects. It is imperative to correct secondary causes prior to initiating conventional lipid-lowering therapy. Guideline-based lipid therapy can then be administered based on the subsequent lipid levels.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- 2024 KSoLA Consensus on Secondary Dyslipidemia
- Dyslipidemia Treatment and Cerebrovascular Disease: Evidence Regarding the Mechanism of Stroke
- The Comparison of Guidelines for Management of Dyslipidemia and the Appropriateness of Them in Korea
- Dyslipidemia Fact Sheets in Korea 2020: an Analysis of Nationwide Population-based Data
- Significant Gap Between Guidelines and Practice in the Management of LDL Cholesterol: Insight From the Survey of the Korean Society of Myocardial Infarction
